Protect Medical Innovation Act of 2018

H.R.184 - Protect Medical Innovation Act of 2017 S.108 - Medical Device Access and Innovation Protection Act

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE

Tax Reform (medical device tax, cash method of accounting, pass-through status, Sec. 179 deduction, cadillac tax, estate tax, pre-tax dollars for health care services) Tax treatment of student loan forgiveness programs for dental care practitioners (e.g., IHS) H.R. 1-Tax Cuts and Jobs Act H.R. 184-Protect Medical Innovation Act H.R. 631-Death Tax Repeal Act of 2017 H.R. 795-Employer Participation in Student Loan Assistance H.R. 6760-Protecting Family and Small Business Tax Cuts Act of 2018 S. 108-Protect Medical Innovation Act

Client expense: $530,000 · Firm income: Not reported

Government targets: Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Treasury, Dept of

H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of PL 114-255, 21st Century Cures Act Implementation of PL-111-148, PPACA H.R. 5997, Ensuring Patient Access to Critical Breakthrough Products Act of 2018 Policies promoting medical innovation Heart Valve Disease Awareness Implementation of PL-115-201, FDA Reauthorization Act of 2017 H.R. 184, Protect Medical Innovation Act of 2017 S. 108, Medical Device Access & Innovation Protection Act Implementation of PL 114-10, MACRA Cybersecurity for Healthcare Industry

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)

Support for H.R. 184 - Protection Medical Innovation Act of 2017. Support for S. 108 - Medical Device Access and Innovation Protection Act. Support for Sec. 301 of H.R. 88 - Shiloh National Military Park Boundary Adjustment and Parker's Crossroads Battlefield Designation Act.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for H.R. 184 - Protection Medical Innovation Act of 2017 & S. 108 - Medical Device Access and Innovation Protection Act. Support for Sec. 301 of H.R. 88 - Shiloh National Military Park Boundary Adjustment and Parker's Crossroads Battlefield Designation Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 108 - Medical Device Access and Innovation Protection Act H.R. 184 - Protect Medical Innovation Act of 2017 Medical imaging reimbursement H.R. 2118 - Medical Device Servicing Safety and Accountability Act HR 2479 Protecting Business Opportunities for Veterans Act Wireless Medical Telemetry Hospital outpatient reimbursement H.R. 1301 - Continuing Appropriations Amendments Act, 2018 HR 6948 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018 Ultrasound Reimbursement Cyber Security

Client expense: $1,510,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Aeronautics & Space Administration (NASA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

H.R. 184, S. 108 bills related to the Medical Device Excise Tax H.R. 88 and related bills/amendments related to extension of certain tax incentives and a 5-year extension of the device tax moratorium H.R. 6756, the American Innovation Act of 2018, related to incentives in the tax code for investment in pre-revenue and start-up medical technology companies Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies

Client expense: $530,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support proposals to repeal the Medical Device Tax, including H.R. 184, the Protect Medical Innovation Act of 2018.

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.184, Protect Medical Innovation Act: Repeal of the medical device excise tax

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.184, Protect Medical Innovation Act: Repeal of the medical device excise tax

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act

Client expense: $430,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues impacting corporate taxation; issues related to implementation of HR 1, Tax Cuts and Jobs Act. HR 184, Protect Medical Innovation Act of 2017, as it relates to the excise tax on medical devices HR 1393/S 540, Mobile Workforce State Income Tax Simplification Act of 2017, as it relates to changes to non-resident personal income tax returns HR 2193, Remote Transaction Parity Act of 2017, as it relates to sourcing issues for interstate sales and telecom tax simplification S 976, Marketplace Fairness Act of 2017, as it relates to sourcing issues for interstate sales and telecom tax simplification HR 6756, American Innovation Act, provisions relating to corporate taxation HR 6757, Family Savings Act, provisions relating to corporate taxation HR 6760, Protecting Family and Small Business Tax Cuts Act of 2018, provisions relating to corporate taxation Draft, Tax Technical and Clerical Corrections Act, provisions related to corporate taxation House Amendment to the Senate Amendment to HR 88, provisions related to corporate tax rate and tax extenders

Client expense: $3,270,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Natl Telecommunications & Information Administration (NTIA), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, White House Office

H.R.184: Protect Medical Innovation Act and H.R.88 as it relates to the medical device tax.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES

H.R.184, Protect Medical Innovation Act of 2018; S.108, Medical Device Access and Innovation Protection Act; H.R.1892, Bipartisan Budget Act of 2018; Section 48 issues related to energy storage; H.R.1, The Tax and Jobs Creation Act - issues surrounding the 163(j) regulations, Global Intangible Low-Taxed Income (GILTI), Foreign-Derived Intangible Income (FDII), Section 965 proposed regulations, and future of Section 385 regulations.

Client expense: $1,020,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

Issues related to the repeal of the medical device excise tax including S.108, the Medical Device Access and Innovation Protection Act and H. R. 184, the Protect Medical Innovation Act of 2017, and H. R.4617.

Client expense: Not reported · Firm income: $80,000

Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, SENATE

Repeal of the excise tax on Medical Devices (S. 108 / H.R. 184) The Death Tax Repeal Act of 2017 (S. 205 / H.R. 631) Last-in/First-out (LIFO) accounting method preservation (no specific bill) Permanent extension of bonus depreciation (no specific bill) Protecting Family and Small Business Tax Cuts Act of 2018 (H.R. 6760) American Innovation Act of 2018 (H.R. 6756) Tax credits to expand recycling infrastructure (no bill)

Client expense: $60,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, President of the U.S., SENATE, Surface Transportation Board (STB), U.S. Trade Representative (USTR)

Loan Repayment for Substance Use Disorder Workforce Mental Health and Substance use treatment workers S 2700, HR 5545- Improving access to substance use disorder treatment, and treatment for those with dual diagnosis S 1905, HR 3931- Supporting Certified Community Behavioral Health Care Centers HR 7141- Workplace Violence Prevention for Health Care and Social Service Workers Improving Mental Health Parity Federal income tax exclusion for employer-sponsored health care HR 173, S 58- Middle Class Health Benefits Tax Repeal Act, 40% tax on employer-sponsored high-cost health benefits HR 184, S 108- Protect Medical Innovation Act of 2018, Medical Device Access and Innovation Protection Act Puerto Rico Medicaid Funding, parity with states

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.

Client expense: $1,320,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 184/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018; H.R.6639 Diabetic Retinopothy Vision Loss and Blindness Prevention Act of 2018

Client expense: Not reported · Firm income: $160,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medical Device excise tax repeal (H.R. 184); taxation of medical technology; R & D tax credit; corporate tax reform.

Client expense: Not reported · Firm income: $160,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 184, Protect Medical Innovation Act, provisions related to the repeal of the medical device tax. S. 108, Medical Device Access and Innovation Protection Act, provisions related to the continued suspension and repeal of the medical device tax. H.R. 4617, Protect Medical Innovation Act, provisions related to repeal of the medical device tax. Issues related to implementation of P.L. 115-97, the Tax Cuts and Jobs Act. Retirement, Savings, and Other Tax Relief Act of 2018 and the Taxpayer First Act of 2018 (Tax Extenders Package attached to H.R. 88), provisions related to the medical device tax suspension.

Client expense: $800,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE

H.R. 184, Protect Medical Innovation Act

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Implementation of H.R. 1, Public Law No. 115-97, Tax Cuts and Jobs Act, H.R.195 Medical Device Tax Repeal S.108 Medical Device Access and Innovation Protection Act H.R. 184 Protect Medical Innovation Act of 2018 HR 1204 Responsible Additions and Increases to Sustain Employee Health Benefits Act HR 1175, S.403 Health Savings Act The Technologies for Energy Security Act, H.R.1090/H.R.1625

Client expense: $670,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

H.R.184 Protect Medical Innovation Act of 2018 S.108 Medical Device Access and Innovation Protection Act Medicare and Medicaid payment quality programs and policies, including: healthcare associated complications, infections, readmission, payment bundling, potentially preventable events and outcomes, transparency, and value based purchasing Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, and patient-centered medical records policies Opioid epidemic related policies Implementation of the Patient Protection and Affordable Care Act (PL 111-148) Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255) Implementation of the Medicare Access CHIP Reauthorization Act (MACRA)(PL 114-10) Implementation of The Health Information Technology for Economic and Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5) Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10) S.428, ACE Kids Act H.R. 3325, ACE Kids Act H.R.3611 The Healthcare Outcomes Act H.R.3922 Championing Healthy Kids Act S.1827 Kids' Insurance Dependable and Secure (KIDS) S.497 Lymphedema Treatment Act H.R. 930 Lymphedema Treatment Act

Client expense: $670,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act H.R. 35, Health Savings Act of 2017 H.R. 143, Health Insurance Industry Antitrust Enforcement Act of 2017 H.R. 173/S. 40/S. 58, Middle Class Health Benefits Tax Repeal Act of 2017 H.R. 184, Protect Medical Innovation Act of 2017 H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes H.R. 246, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act H.R. 394/S. 85, Restoring Access to Medication Act of 2017 H.R. 620, ADA Education and Reform Act of 2017 H.R. 849/S. 260, Protecting Seniors Access to Medicare Act H.R. 1101, Small Business Health Fairness Act of 2017 H.R. 1175/S. 403, Health Savings Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 1313, Preserving Employee Wellness Programs Act H.R. 1625, Consolidated Appropriations Act, 2018 H.R. 1892, Bipartisan Budget Act of 2018 H.R. 3331, To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology H.R. 3798, Save American Workers Act of 2017 H.R. 4284, Indexing Narcotics, Fentanyl, and Opioids (INFO) Act of 2018 H.R. 4616, To amend the Patient Protection and Affordable Care Act to provide for a temporary moratorium on the employer mandate and to provide for a delay in the implementation of the excise tax on high cost employer-sponsored health coverage H.R. 4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication H.R. 4619, To amend the Patient Protection and Affordable Care Act to provide temporary relief from the annual fee imposed on health insurance providers, to the extent that such fee is due to Puerto Rican health insurance H.R. 4620, Protecting Families and Small Businesses Act of 2017 H.R. 4978/S. 2410, Chronic Disease Management Act of 2018 H.R. 5009, Jessies Law H.R. 5041, Safe Disposal of Unused Medication Act H.R. 5138, Bipartisan HSA Improvement Act of 2018 H.R. 5272, To provide additional guidance to grantees seeking funding to treat or prevent mental health or substance use disorders H.R. 5582, Abuse Deterrent Access Act of 2018 H.R. 5788, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2018 H.R. 5892, To establish an Advisory Committee on Opioids and the Workplace to advise the Secretary of Labor on actions the Department of Labor can take to address the impact of opioid abuse on the workplace H.R. 6199, Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018 H.R. 6311, Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018 S. 108, Medical Device Access and Innovation Protection Act S. 191, Patient Freedom Act of 2017 S. 222, Obamacare Replacement Act S. 251, Protecting Medicare from Executive Action Act of 2017 S. 974, Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 S. 1835, Lower Premiums Through Reinsurance Act of 2017 S. 1850, Protecting Jessica Grubb's Legacy Act S. 1859, Healthcare Tax Relief Act S. 1978, Small Business and Family Health Tax Relief Act of 2017 S. 2004, Combating the Opioid Epidemic Act S. 2164, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings S. 3057, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2018 Draft legislation to stabilize individual market premiums for the 2018 and 2019 plan years and provide meaningful State flexibility (Alexander-Murray) Proposed regulation on health reimbursement arrangements and other account-based group health plans (83 Fed. Reg. 54,420-54,477, October 29, 2018) Final Regulation, definition of employer under Section 3(5) of ERISA - association health plans (83 Fed. Reg. 28912-28964, June 21, 2018) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part D's Non-Interference Clause from repeal Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; House Republican Taskforce on Health Care report; A Better Way to Fix Health Care; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; Executive Order 13813, Promoting Healthcare Choice and Competition; addressing the opioids crisis, including end-stage renal disease; balance or surprise billing; single-payer health care options; aligning 42 CFR Part 2 with the Health Insurance Portability and Accountability Act (P.L. 104-191) for the purposes of treatment, payment, and health car operation (TPO); inclusion of prescription drug pricing on 2019 congressional agenda; general advocacy for Congress to reach a working quorum for the board of the Export-Import Bank; section 301 of the Trade Act of 1974; U.N. Convention on the Assignment of Receivables in Int'l Trade

Client expense: $15,950,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Social Security Administration (SSA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

H.R. 184, S. 108 Medical Device Access and Innovation Protection Act. Bills related to the Medical Device Excise Tax. Issues related to improved awareness of cardiovascular disease and the new field of heart recovery. Issues related to access for heart assist devices.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2953/S. 2164 - Preventive Health Savings Act H.R. 5963 - To delay the reimposition of the annual fee on health insurance providers until after 2020 H.R. 6082- Overdose Prevention and Safety (OPPS) act H.R. 6, SUPPORT for Patients and Communities Act H.R.184, the Protect Medical Innovation Act of 2017 H.R. 6378, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018 H.R. 1822, the Good Samaritan Health Professionals Act S. 3496, the Improving Seniors Access to Quality Benefits Act S. 3497, the Medicare Advantage Quality Payment Relief Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2953/S. 2164 - Preventive Health Savings Act H.R. 5963 - To delay the reimposition of the annual fee on health insurance providers until after 2020 H.R. 6082- Overdose Prevention and Safety (OPPS) act H.R. 6, SUPPORT for Patients and Communities Act H.R.184, the Protect Medical Innovation Act of 2017 H.R. 6378, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018 H.R. 1822, the Good Samaritan Health Professionals Act S. 3496, the Improving Seniors Access to Quality Benefits Act S. 3497, the Medicare Advantage Quality Payment Relief Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 184 - Protect Medical Innovation Act of 2017 S. 108 - Medical Device Access and Innovation Protection Act S. 1827- KIDS Act of 2017

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Tax issues affecting the industry, including repeal of the medical device excise tax. H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.88, Retirement, Savings, and Other Tax Relief Act of 2018 and Taxpayer First Act of 2018.

Client expense: $320,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

H.R. 184 - Protect Medical Innovation Act of 2017 S. 108 - Medical Device Access and Innovation Protection Act H.R. 1628 - American Health Care Act of 2017

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-H.R. 173/S.58: Middle Class Health Benefits Tax Repeal Act of 2017 -Cap on tax exclusion for employer-based health insurance -Prescription Drugs: Prices -S. 3120: HEAL Act of 2018 (provisions related to expanded funding for opioid treatment and -H.R. 184: Protect Medical Innovation Act of 2018: provisions related to expanding funding for opioid treatment & prevention services -H.R. 3798: Save American Workers Act of 2017: Provisions related to modifying the ACA shared responsibility requirements -NAFTA: Two provisions affecting Prescription Drug Prices -H.R. 1902: Social Security 2100 Act: benefits expansion -Retiree Healthcare-IRC Code Section 420 Transfer -S. 3775: Affordable Drug Manufacturing Act of 2018

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, U.S. Trade Representative (USTR)

H.R. 184 - Protect Medical Innovation of 2015 S. 108 - Medical Device Access and Innovation Protection Act device tax repeal H.R. 1- Tax Cuts and Jobs Act H.R. 195 - CR

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 108- Medical Device Access and Innovation Protection Act H.R. 184 - Protect Medical Innovation Act of 2017 H.R. 1- Tax Cuts and Jobs Act H.R. 195 - CR

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of Continuing Appropriations Act of 2018; H.R. 6639 Diabetic Retinopathy Vision Loss and Blindness Prevention Act, Medical Device Tax Repeal (HR 184)

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Diabetic Eye Disease Prevention Act (H.R. 4642). Safe Patient Handling, FDA Reform, Technology research. Implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); Diabetic RetinopathyVision Loss and Blindness Prevention Act of 2018; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of continuing Appropriations; Medical Device Tax Repeal (HR 184)

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medical Device Tax Repeal (HR 184); corporate tax reform; taxation of medical technology

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ACA Implementation Association Health Plans Blueprint to Lower Drug Prices and Reduce Out of Pocket Costs Cadillac Tax Delay/Repeal H.R. 6505, Medicare Negotiation and Competitive Licensing Act of 2018 Health Care Reform Health Insurance Tax Health Savings Accounts H.R. 184, Protect Medical Innovation Act H.R. 6199, Restoring Access to Medication and Mordernizing Health Savings Account International Pricing Index Model for Medicare Part B Drugs ANPRM Medical Device Tax Medicare for All/Single Payer Medicare Part D Opioid Crisis Pharmaceutical Pricing Transparency Tax Treatment of Employer-Sponsored Health Care Wellness Plans

Client expense: $2,840,000 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS), Central Intelligence Agency (CIA), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Export-Import Bank of the United States (EXIM Bank), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

ACA: excise tax on high-value multi-employer plans H.R. 2050 Middle Class Health Benefits Tax Repeal Act ACA: Individual Responsibility Mandate, reinsurance issue, cost sharing reimbursement issue, medicare/medicaid issues. H.R 184, Protect Medical Innovation Act S. 108, Medical Device Access and Innovation Protection Act

Client expense: $400,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Federal Aviation Administration (FAA), Federal Motor Carrier Safety Administration, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office

In support of the Protect Medical Innovation Act of 2017 (S 108/HR 184) - to repeal the medical device excise tax

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medical Device Tax Repeal - H.R. 184 and S. 108

Client expense: $970,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

Public Law 115-97 - Implementation of Comprehensive/Corporate Tax Reform - Includes lower corporate tax rate, research credit transition, base erosion, International Tax Reform Provisions, and tax Extender Provisions S108 & HR 184 - Legislation to repeal the 2.3% Medical Device Tax HR 88, as amended, by the US House of Representatives - Legislation to extend the suspension of the Medical Device Tax for a further 5 years

Client expense: $450,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE